EMULSION VEHICLES AND VASOCONSTRICTOR ACTIVITY I57 (7) W. Schuede, Unpublished results (1975). (8) A. S. Anderson, Unpublished results (1976). (9) A. W. McKenzie and R. B. Stoughtin, Methods for comparing percutaneous absorption of steroids, Arch. Dermatol., 86, 608-610 (1962). (10) M. Barr, Percutaneous absorption, J. Phar. Sci., 51(5), 395-409 (1962). (11) C. N. Frazier and I. H. Blank, A Formulary for External Therapy ofTheSkin (C. C. Thomas, Spring- field, IL, 1954), pp. 37-69. (12) B. W. Barry, Dermatological Formulations: Percutaneous Absorption (Marcel Dekker, Inc., New York, 1983), pp. 153-172. (13) K. P. Wittern, A. Ansmann, R. Huttinger, D. Billek, E. Charlet, L. Hoenen, K. Kuczera, L. Motitschke, J. Quack, L. Selb, I. Umbach, and G. Wolff, Stability testing of cosmetic emulsion. Experiences of a circular test, Cosmet. Toil., 100, 33-39 (1985). (14) The United States Pharmacopeia, United States Pharmacopeial Convention, Inc., Rockville, MD, 21st revision, pp. 508, 696-697, 755-756, 810-811 (1985). (15) I. H. Blank, Toxicol. Appl. Pharmacol., Suppl. 3, 23-29 (1969). (16) K. H. Burdick, J. K. Haleblian, B. J. Poulsen, and S. E. Cobner, Cortocosteroid ointments: Com- parison by two human bioassays, Curr. Ther. Res. Clin. Exp., 15, 233-242 (1973). (17) R. C. Cornell and R. B. Stoughton, Use of glucocorticosteroids in psoriasis, Pharmacol. Ther., 11, 397-508 (1980).